PTPI: Petros Kompaniya qiymatining sof foydaga nisbati

Petros Pharmaceuticals Inc (PTPI) korporativ emblemasi va logotipi

Petros Pharmaceuticals (PTPI) bozor qiymati dinamikasi joriy P/E koeffitsiyentining -0.10 ekanligini aks ettiradi. Biznes dori-darmonlar hisobi va qadoqlash robototexnikasi uchun bulutli IT yechimlariga tayanadi, bu esa xodimlar xarajatlarini kamaytiradi. Erkaklar salomatligi uchun mo'ljallangan mahsulotlarning onlayn savdosi orqali daromadlar o'smoqda. Biroq, noyob ustunliklarning yetishmasligi raqamli texnologik gigantlarning kengayishi va narxlar urushlari tufayli bozor ulushining yo'qolishiga olib kelmoqda.

PTPI Petros Pharma: Narx-foyda koeffitsiyenti 04.07.2022 - 24.05.2025 oraligʻida

Petros Pharmaceuticals Inc (PTPI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Petros Pharmaceuticals Inc - PTPI
Petros Pharmaceuticals, Inc. yetakchi tovari

P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi va biznesning o'sish sur'atlariga oid investorlar kutganlarini aks ettiradi. Petros Pharmaceuticals (PTPI) uchun ushbu parametr bozarning mualliflik huquqi bilan himoyalangan dori vositalari uchun to'lov qilishga bo'lgan tayyorgarligini o'lchaydi. Narx-foyda koeffitsiyenti tendentsiyasini tahlil qilish generik dori vositalarining kengayishi va telemeditsinaning kapitalizatsiyaga ta'sirini ochib beradi. Koeffitsiyentning pasayishi distributsiyaga oid xatarlarning qayta baholanishini anglatadi va aktivning fundamental jozibadorligi ko'rsatkichi bo'lib xizmat qiladi.

Raqobatdosh kompaniyalar tahlili

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|HYFT: Narxning foydaga nisbati|ABVC BioPharma Inc. (ABVC) - Narxning foydaga nisbati|cumberlandpharma.com (CPIX) - P/E multiplikatori|QNTM (Quantum BioPharma) - P/E multiplikatori|FGEN: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TELO|P/E multiplikatori Rani Therapeutics Holdings (RANI)|P/E multiplikatori SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Kapitalizatsiyaning foydaga nisbati|LEXX - Narxning foydaga nisbati|PULM (Pulmatrix) - Narx-foyda multiplikatori|Pheton Holdings Ltd (PTHL) - Narxning foydaga nisbati|Aptorum - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti LYRA|Narx-foyda koeffitsiyenti Impact BioMedical Inc (IBO)|P/E multiplikatori TNFA|YCBD: Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati PainReform PRFX|altamiratherapeutics.com (CYTO) - Kapitalizatsiyaning foydaga nisbati|LIPO: Narx-foyda koeffitsiyenti|OPTN (optinose.com) - Narx-foyda multiplikatori|PIRS: P/E multiplikatori|PROC - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)